• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N6-甲基腺嘌呤诱导的 LINC00667 通过 m6A/KIAA1429 正反馈环促进乳腺癌进展。

N6-methyladenine- induced LINC00667 promoted breast cancer progression through m6A/KIAA1429 positive feedback loop.

机构信息

School of Medicine, South China University of Technology, Guangzhou, China.

Department of General Surgery, The Sixth Medical Center of PLA General Hospital of Beijing, Beijing, China.

出版信息

Bioengineered. 2022 May;13(5):13462-13473. doi: 10.1080/21655979.2022.2077893.

DOI:10.1080/21655979.2022.2077893
PMID:36700472
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9275968/
Abstract

Increasing evidence supports that N-methyladenine (mA) and long noncoding RNAs (lncRNAs) both act as master regulators involved in breast cancer (BC) tumorigenesis at epigenetic modification level. Here, our research tries to unveil the interaction of mA and lncRNAs on BC progression and explore the underlying regulatory mechanism. In the current study, we found that LINC00667 was mA-modified lncRNA, which was up-regulated upon the overexpression of KIAA1429. The high expression of LINC00667 was correlated with the prognosis of BC patients. Bio-functional assays indicated that LINC00667 promoted the proliferation and migration of BC cells. Mechanistic assays illustrated that KIAA1429 targeted the mA modification site of LINC00667 and enhanced its mRNA stability. Moreover, LINC00667 positively regulated the KIAA1429 via sponging miR-556-5p, forming a KIAA1429/mA/LINC00667/miR-556-5p feedback loop. Collectively, the central findings of our study suggest that KIAA1429-induced LINC00667 exerted its functions as an oncogene in BC progression through mA-dependent feedback loop.

摘要

越来越多的证据表明,N6-甲基腺嘌呤(mA)和长非编码 RNA(lncRNA)都可以作为表观遗传修饰水平参与乳腺癌(BC)肿瘤发生的主要调控因子。在这里,我们的研究试图揭示 mA 和 lncRNAs 对 BC 进展的相互作用,并探讨其潜在的调控机制。在本研究中,我们发现 LINC00667 是 mA 修饰的 lncRNA,其表达水平在 KIAA1429 过表达时上调。LINC00667 的高表达与 BC 患者的预后相关。生物功能分析表明,LINC00667 促进了 BC 细胞的增殖和迁移。机制分析表明,KIAA1429 靶向 LINC00667 的 mA 修饰位点,增强其 mRNA 稳定性。此外,LINC00667 通过海绵吸附 miR-556-5p 正向调节 KIAA1429,形成 KIAA1429/mA/LINC00667/miR-556-5p 反馈环。综上所述,本研究的主要发现表明,KIAA1429 诱导的 LINC00667 通过 mA 依赖性反馈环发挥其作为 BC 进展中的癌基因的功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dab9/9275968/d45a5c5528ce/KBIE_A_2077893_F0006_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dab9/9275968/f6e6c33a66d4/KBIE_A_2077893_UF0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dab9/9275968/7ede0a808140/KBIE_A_2077893_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dab9/9275968/978b0ebcf673/KBIE_A_2077893_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dab9/9275968/10e8878b4aa0/KBIE_A_2077893_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dab9/9275968/737663886ae2/KBIE_A_2077893_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dab9/9275968/a7bc8105c732/KBIE_A_2077893_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dab9/9275968/d45a5c5528ce/KBIE_A_2077893_F0006_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dab9/9275968/f6e6c33a66d4/KBIE_A_2077893_UF0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dab9/9275968/7ede0a808140/KBIE_A_2077893_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dab9/9275968/978b0ebcf673/KBIE_A_2077893_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dab9/9275968/10e8878b4aa0/KBIE_A_2077893_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dab9/9275968/737663886ae2/KBIE_A_2077893_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dab9/9275968/a7bc8105c732/KBIE_A_2077893_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dab9/9275968/d45a5c5528ce/KBIE_A_2077893_F0006_OC.jpg

相似文献

1
N6-methyladenine- induced LINC00667 promoted breast cancer progression through m6A/KIAA1429 positive feedback loop.N6-甲基腺嘌呤诱导的 LINC00667 通过 m6A/KIAA1429 正反馈环促进乳腺癌进展。
Bioengineered. 2022 May;13(5):13462-13473. doi: 10.1080/21655979.2022.2077893.
2
Biological networks in gestational diabetes mellitus: insights into the mechanism of crosstalk between long non-coding RNA and N-methyladenine modification.妊娠期糖尿病的生物学网络:长链非编码 RNA 和 N6-甲基腺嘌呤修饰相互作用机制的研究进展。
BMC Pregnancy Childbirth. 2022 May 3;22(1):384. doi: 10.1186/s12884-022-04716-w.
3
Yin Yang 1-induced LINC00667 up-regulates pyruvate dehydrogenase kinase 1 to promote proliferation, migration and invasion of cholangiocarcinoma cells by sponging miR-200c-3p.阴阳 1 诱导 LINC00667 上调丙酮酸脱氢酶激酶 1,通过海绵 miR-200c-3p 促进胆管癌细胞的增殖、迁移和侵袭。
Hum Cell. 2021 Jan;34(1):187-200. doi: 10.1007/s13577-020-00448-1. Epub 2020 Oct 10.
4
KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3.KIAA1429 通过 GATA3 的 N6-甲基腺苷依赖性转录后修饰促进肝癌进展。
Mol Cancer. 2019 Dec 19;18(1):186. doi: 10.1186/s12943-019-1106-z.
5
N-Methyladenosine-regulated LINC00675 suppress the proliferation, migration and invasion of breast cancer cells via inhibiting miR-513b-5p.N6-甲基腺苷调控的 LINC00675 通过抑制 miR-513b-5p 抑制乳腺癌细胞的增殖、迁移和侵袭。
Bioengineered. 2021 Dec;12(2):10690-10702. doi: 10.1080/21655979.2021.2001905.
6
N6-methyladenosine-mediated upregulation of LINC00520 accelerates breast cancer progression via regulating miR-577/POSTN axis and downstream ILK/AKT/mTOR signaling pathway.N6-甲基腺苷介导的 LINC00520 上调通过调节 miR-577/POSTN 轴和下游 ILK/AKT/mTOR 信号通路加速乳腺癌进展。
Arch Biochem Biophys. 2022 Oct 30;729:109381. doi: 10.1016/j.abb.2022.109381. Epub 2022 Aug 23.
7
N6-methyladenosine (m6A)-mediated up-regulation of long noncoding RNA LINC01320 promotes the proliferation, migration, and invasion of gastric cancer via miR495-5p/RAB19 axis.N6-甲基腺苷(m6A)介导的长非编码 RNA LINC01320 的上调通过 miR495-5p/RAB19 轴促进胃癌的增殖、迁移和侵袭。
Bioengineered. 2021 Dec;12(1):4081-4091. doi: 10.1080/21655979.2021.1953210.
8
CREBZF mRNA nanoparticles suppress breast cancer progression through a positive feedback loop boosted by circPAPD4.CREBZF mRNA 纳米颗粒通过 circPAPD4 增强的正反馈回路抑制乳腺癌进展。
J Exp Clin Cancer Res. 2023 Jun 1;42(1):138. doi: 10.1186/s13046-023-02701-5.
9
N-methyladenosine methyltransferase KIAA1429 elevates colorectal cancer aerobic glycolysis via HK2-dependent manner.N6-甲基腺苷甲基转移酶 KIAA1429 通过 HK2 依赖性方式促进结直肠癌细胞有氧糖酵解。
Bioengineered. 2022 May;13(5):11923-11932. doi: 10.1080/21655979.2022.2065952.
10
Long non-coding RNA LPP-AS2 promotes glioma tumorigenesis via miR-7-5p/EGFR/PI3K/AKT/c-MYC feedback loop.长链非编码 RNA LPP-AS2 通过 miR-7-5p/EGFR/PI3K/AKT/c-MYC 反馈环促进胶质瘤发生。
J Exp Clin Cancer Res. 2020 Sep 22;39(1):196. doi: 10.1186/s13046-020-01695-8.

引用本文的文献

1
KIAA1429-mediated ZFPM2-AS1 mA modification promotes the proliferation, migration and invasion of osteosarcoma cells.KIAA1429介导的ZFPM2-AS1 mA修饰促进骨肉瘤细胞的增殖、迁移和侵袭。
Oncol Lett. 2025 Jul 21;30(4):453. doi: 10.3892/ol.2025.15199. eCollection 2025 Oct.
2
The Multifaceted Role of VIRMA, a Core Component of the Methyltransferase Complex, in Cancer and Cancer Therapy.VIRMA(甲基转移酶复合物的核心成分)在癌症及癌症治疗中的多方面作用
Biomolecules. 2025 Jun 22;15(7):912. doi: 10.3390/biom15070912.
3
KIAA1429 promotes non-small-cell lung cancer cell proliferation through the TRERNA1/HOXA6 axis.

本文引用的文献

1
The Emerging Role of Non-Coding RNAs in the Regulation of Virus Replication and Resultant Cellular Pathologies.非编码 RNA 在病毒复制及由此产生的细胞病变中的调控作用日益凸显。
Int J Mol Sci. 2022 Jan 13;23(2):815. doi: 10.3390/ijms23020815.
2
LncRNAs and the Angiogenic Switch in Cancer: Clinical Significance and Therapeutic Opportunities.长链非编码 RNA 与癌症中的血管生成开关:临床意义和治疗机会。
Genes (Basel). 2022 Jan 15;13(1):152. doi: 10.3390/genes13010152.
3
New insights into the interplay between long non-coding RNAs and RNA-binding proteins in cancer.
KIAA1429通过TRERNA1/HOXA6轴促进非小细胞肺癌细胞增殖。
Sci Rep. 2025 Jul 10;15(1):24858. doi: 10.1038/s41598-025-09441-w.
4
Recent Advances in the Mutual Regulation of m6A Modification and Non-Coding RNAs in Atherosclerosis.动脉粥样硬化中m6A修饰与非编码RNA相互调控的研究进展
Int J Gen Med. 2025 Feb 25;18:1047-1073. doi: 10.2147/IJGM.S508197. eCollection 2025.
5
CancerHubs: a systematic data mining and elaboration approach for identifying novel cancer-related protein interaction hubs.癌症枢纽:一种用于识别新型癌症相关蛋白质相互作用枢纽的系统数据挖掘与阐释方法。
Brief Bioinform. 2024 Nov 22;26(1). doi: 10.1093/bib/bbae635.
6
N6-Methyladenosine Methyltransferase Component KIAA1429 Is a Potential Target of Cancer Therapy.N6-甲基腺苷甲基转移酶组件 KIAA1429 是癌症治疗的潜在靶点。
Biomolecules. 2024 Oct 17;14(10):1319. doi: 10.3390/biom14101319.
7
Exosomal lncRNAs as regulators of breast cancer chemoresistance and metastasis and their potential use as biomarkers.外泌体长链非编码RNA作为乳腺癌化疗耐药和转移的调节因子及其作为生物标志物的潜在用途。
Front Oncol. 2024 Aug 1;14:1419808. doi: 10.3389/fonc.2024.1419808. eCollection 2024.
8
Functions of methyltransferase-like 3 in breast cancer: pathogenesis, drug resistance, and therapeutic target.甲基转移酶样蛋白 3 在乳腺癌中的作用:发病机制、耐药性和治疗靶点。
Breast Cancer Res. 2024 Jul 3;26(1):110. doi: 10.1186/s13058-024-01869-8.
9
Role and mechanism of KIAA1429 in regulating cellular ferroptosis and radioresistance in colorectal cancer.KIAA1429 在调控结直肠癌细胞铁死亡和放射抵抗中的作用及机制。
Biomol Biomed. 2024 Oct 17;24(6):1669-1681. doi: 10.17305/bb.2024.10313.
10
Analysis of m6A-regulated genes and subtype classification in lupus nephritis.m6A 调控基因分析及狼疮肾炎的亚型分类。
BMC Nephrol. 2024 Apr 3;25(1):119. doi: 10.1186/s12882-024-03549-3.
长非编码 RNA 与 RNA 结合蛋白在癌症中的相互作用的新见解。
Cancer Commun (Lond). 2022 Feb;42(2):117-140. doi: 10.1002/cac2.12254. Epub 2022 Jan 12.
4
Non-Coding RNA m6A Modification in Cancer: Mechanisms and Therapeutic Targets.癌症中的非编码RNA m6A修饰:机制与治疗靶点
Front Cell Dev Biol. 2021 Dec 22;9:778582. doi: 10.3389/fcell.2021.778582. eCollection 2021.
5
N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy.N6-甲基腺苷 RNA 修饰在肿瘤免疫微环境中的作用:免疫治疗的新意义。
Front Immunol. 2021 Dec 9;12:773570. doi: 10.3389/fimmu.2021.773570. eCollection 2021.
6
The Relationship Between the Network of Non-coding RNAs-Molecular Targets and N6-Methyladenosine Modification in Colorectal Cancer.非编码RNA-分子靶点网络与结直肠癌中N6-甲基腺苷修饰之间的关系
Front Cell Dev Biol. 2021 Dec 6;9:772542. doi: 10.3389/fcell.2021.772542. eCollection 2021.
7
RNA N6-methyladenosine in nonocular and ocular disease.非眼部和眼部疾病中的RNA N6-甲基腺苷
J Cell Physiol. 2022 Mar;237(3):1686-1710. doi: 10.1002/jcp.30652. Epub 2021 Dec 15.
8
The Emerging Role of m6A Modification in Regulating the Immune System and Autoimmune Diseases.m6A修饰在调节免疫系统和自身免疫性疾病中的新兴作用
Front Cell Dev Biol. 2021 Nov 16;9:755691. doi: 10.3389/fcell.2021.755691. eCollection 2021.
9
N-methyladenosine (mA)-mediated lncRNA DLGAP1-AS1enhances breast canceradriamycin resistance through miR-299-3p/WTAP feedback loop.N6-甲基腺苷(m6A)介导的长链非编码 RNA DLGAP1-AS1 通过 miR-299-3p/WTAP 反馈环增强乳腺癌阿霉素耐药性。
Bioengineered. 2021 Dec;12(2):10935-10944. doi: 10.1080/21655979.2021.2000198.
10
Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma.N6-甲基腺苷相关长链非编码RNA与肺腺癌肿瘤免疫微环境及临床预后的关系
Front Genet. 2021 Oct 20;12:714697. doi: 10.3389/fgene.2021.714697. eCollection 2021.